ID   PER-377
AC   CVCL_A475
SY   PER377
DR   Cosmic; 1130242
DR   Wikidata; Q54947186
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7536459;
RX   PubMed=7541097;
RX   PubMed=12883040;
RX   PubMed=14671638;
RX   PubMed=17117183;
CC   Doubling time: 3.6 days (PubMed=7536459); 66 hours (PubMed=17117183).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=17117183
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D21S11: 31.2,32
ST   D2S1338: 19,21
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A474 ! PER-365
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=7536459; DOI=10.1002/gcc.2870120307;
RA   Kees U.R., Campbell L.J., Ford J., Willoughby M.L.N., Peroni S.E.,
RA   Ranford P.R., Garson O.M.;
RT   "New translocation t(2;13)(p12;q34) and rearrangement of the MLL gene
RT   in a childhood leukemia cell line.";
RL   Genes Chromosomes Cancer 12:201-208(1995).
//
RX   PubMed=7541097;
RA   Kees U.R., Ashman L.K.;
RT   "Synergistic action of interleukin-2 and Steel factor (SLF) on a human
RT   T lymphoblastoid cell line.";
RL   Leukemia 9:1046-1050(1995).
//
RX   PubMed=12883040;
RA   Kees U.R., Ford J., Watson M., Murch A.R., Ringner M., Walker R.L.,
RA   Meltzer P.S.;
RT   "Gene expression profiles in a panel of childhood leukemia cell lines
RT   mirror critical features of the disease.";
RL   Mol. Cancer Ther. 2:671-677(2003).
//
RX   PubMed=14671638; DOI=10.1038/sj.leu.2403236;
RA   Drexler H.G., Quentmeier H., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   MLL gene alterations.";
RL   Leukemia 18:227-232(2004).
//
RX   PubMed=17117183; DOI=10.1038/sj.bjc.6603447;
RA   Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J.,
RA   Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R.;
RT   "Authenticity and drug resistance in a panel of acute lymphoblastic
RT   leukaemia cell lines.";
RL   Br. J. Cancer 95:1537-1544(2006).
//